Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Quality Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Quality Index of 1.37x as of September 2025. Operating cash flow of ₩4.70 Billion exceeds net income of ₩3.42 Billion, indicating high earnings quality where cash backs reported profits. Explore 002800 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinsin Pharmaceutical Co. Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Sinsin Pharmaceutical Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year earnings quality comparison for Sinsin Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see Sinsin Pharmaceutical Co. Ltd (002800) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩5.94 Billion | ₩4.81 Billion | ▲ +46.0% |
| 2023 | 0.85x | ₩3.93 Billion | ₩4.65 Billion | ▼ -31.6% |
| 2022 | 1.24x | ₩5.46 Billion | ₩4.41 Billion | ▼ -75.9% |
| 2020 | 5.14x | ₩1.87 Billion | ₩362.66 Million | ▲ +344.0% |
| 2019 | -2.11x | ₩-4.51 Billion | ₩2.14 Billion | ▼ -888.4% |
| 2018 | 0.27x | ₩774.24 Million | ₩2.90 Billion | ▼ -78.9% |
| 2017 | 1.27x | ₩4.57 Billion | ₩3.60 Billion | ▲ +101.4% |
| 2016 | 0.63x | ₩2.79 Billion | ₩4.44 Billion | ▼ -53.3% |
| 2015 | 1.35x | ₩5.24 Billion | ₩3.89 Billion | — |